Clinical Trial Update: BAY-43-9006 in Advanced, Metastatic Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial of sorafenib (BAY-43-9006) in advanced soft tissue sarcoma has completed enrollment, according to the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED